Raptor Pharmaceuticals Corp has revealed that its stockholders have approved the proposals to complete the proposed merger with TorreyPines Therapeutics. According to the company, the merger is expected
Sinochem Corp has entered into a Heads of Agreement with Nufarm in relation to a non-binding proposal for Sinochem to acquire all of the issued ordinary shares in
Mitsubishi Chemical Corporation (MCC) and PTT Public Company (PTT) have signed a memorandum of understanding on jointly conducting a study for business development of bio-polybutylene succinate, a bio-degradable
The FDA has approved pralatrexate for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Research on drugs of this class began in the 1950s at SRI
Addex Pharmaceuticals has completed the enrollment in the phase IIb trial of ADX10059 as a monotherapy in patients with gastroesophageal reflux disease (GERD). ADX10059 is a first-in-class reflux
Sanofi-aventis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a
Afinitor (everolimus) has been licensed for the treatment of advanced kidney cancer after failure of treatments which prevent the growth of the tumour’s blood vessels. The growth of
Wyeth Pharmaceuticals has announced that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the company’s pneumococcal conjugate
Sensitel has announced the release of VeriSupply secure document management subscription service. Designed as a business network, VeriSupply addresses the need for secure and discrete communication across in
Shengtai Pharmaceutical, manufacturer and distributor of pharmaceutical grade glucose products in China, has posted its financial results with 7% decrease in the revenue in the fourth quarter and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.